Literature DB >> 17625607

MicroRNA losses in the frequently deleted region of 7q in SMZL.

E Ruiz-Ballesteros, M Mollejo, M Mateo, P Algara, P Martínez, M A Piris.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17625607     DOI: 10.1038/sj.leu.2404853

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

2.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

3.  Aberrant microRNA expression in tumor mycosis fungoides.

Authors:  E Papadavid; M Braoudaki; M Bourdakou; A Lykoudi; V Nikolaou; G Tounta; A Ekonomidi; E Athanasiadis; G Spyrou; C Antoniou; S Kitsiou-Tzeli; D Rigopoulos; A Kolialexi
Journal:  Tumour Biol       Date:  2016-09-13

4.  An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.

Authors:  A James Watkins; Rifat A Hamoudi; Naiyan Zeng; Qingguo Yan; Yuanxue Huang; Hongxiang Liu; Jianzhong Zhang; Esteban Braggio; Rafael Fonseca; Laurence de Leval; Peter G Isaacson; Andrew Wotherspoon; Ellen D McPhail; Ahmet Dogan; Ming-Qing Du
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  MicroRNA signatures in B-cell lymphomas.

Authors:  L Di Lisio; M Sánchez-Beato; G Gómez-López; M E Rodríguez; S Montes-Moreno; M Mollejo; J Menárguez; M A Martínez; F J Alves; D G Pisano; M A Piris; N Martínez
Journal:  Blood Cancer J       Date:  2012-02-17       Impact factor: 11.037

Review 6.  miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.

Authors:  Nicola Amodio; Marco Rossi; Lavinia Raimondi; Maria Rita Pitari; Cirino Botta; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Oncotarget       Date:  2015-05-30

Review 7.  Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA.

Authors:  Jacob E Robinson; Christine E Cutucache
Journal:  Oncotarget       Date:  2018-07-06

8.  Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma.

Authors:  Enrico Munari; Marianna Rinaldi; Achille Ambrosetti; Massimiliano Bonifacio; Angela Bonalumi; Marco Chilosi; Alberto Zamò
Journal:  Virchows Arch       Date:  2012-10-14       Impact factor: 4.064

Review 9.  Molecular signature in HCV-positive lymphomas.

Authors:  Valli De Re; Laura Caggiari; Marica Garziera; Mariangela De Zorzi; Ombretta Repetto
Journal:  Clin Dev Immunol       Date:  2012-08-16

Review 10.  MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy?

Authors:  Charles Henderson Lawrie
Journal:  J Cell Mol Med       Date:  2008-07-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.